Next scheduled review date: 25 July 2029 More on this topic What Is Off-Label Prescribing
UBT251 is classified as a Class 1 innovative drug in China and has recently been approved for clinical trials in adults with type 2 diabetes, fatty liver disease, and chronic kidney disease
Guidelines include prescription options after OTC steps fail
Its particularly beneficial for individuals experiencing fatigue or B12 deficiency, common in strict vegetarians, older adults, or those with certain medical conditions
Disorders Associated with MSL Associated disorders include liver disease, dyslipidemia, metabolic syndrome, hypertriglyceridemia, hypothyroidism, diabetes mellitus, and peripheral and autonomic neuropathy (Figure 11)